{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T18:37:28Z","timestamp":1785609448645,"version":"3.56.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.thromres.2014.05.009","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T12:15:31Z","timestamp":1400069731000},"page":"376-383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["In vitro and in vivo analysis of the antithrombotic and toxicological profile of new antiplatelets N-acylhydrazone derivatives and development of nanosystems"],"prefix":"10.1016","volume":"134","author":[{"given":"Pl\u00ednio Cunha","family":"Sathler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2805-9384","authenticated-orcid":false,"given":"Andr\u00e9 Luiz","family":"Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Rangel","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Cl\u00e1udio Rodrigues Pereira","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio Mendes","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0128-7026","authenticated-orcid":false,"given":"Alessandro Kappel","family":"Jord\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Cl\u00e1udia","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cec\u00edlia Bastos","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor Francisco","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Eponina","family":"Carvalho-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Chung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena Carla","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2014.05.009_bb0005","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1590\/S0100-40422010000100030","article-title":"Secondary metabolites from vegetal origin: a potential source of antithrombotic drugs","volume":"33","author":"Chaves","year":"2010","journal-title":"Quim Nova"},{"key":"10.1016\/j.thromres.2014.05.009_bb0010","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/CIR.0b013e3182456d46","article-title":"Executive summary: heart disease and stroke statistics\u20132012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2014.05.009_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1076029610385222","article-title":"Review: Antiplatelet drugs: what comes next?","volume":"17","author":"Kei","year":"2011","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.thromres.2014.05.009_bb0020","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2174\/138161212799504777","article-title":"Cardiovascular risk and inflammation: pathophysiological mechanisms, drug design, and targets","volume":"18","author":"Gasparyan","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.thromres.2014.05.009_bb0025","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1016\/j.bmc.2009.03.053","article-title":"Synthesis, antiplatelet and in silico evaluations of novel N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides","volume":"17","author":"Jord\u00e3o","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.thromres.2014.05.009_bb0030","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1039\/c2cs90005j","article-title":"Nanomedicine","volume":"41","author":"Caruso","year":"2012","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.thromres.2014.05.009_bb0035","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.2147\/IJN.S31632","article-title":"Preparation and characterization of polysaccharide-based nanoparticles with anticoagulant activity","author":"Da Silva","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.thromres.2014.05.009_bb0040","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4314\/tjpr.v5i1.14634","article-title":"Nanoparticles-a review","volume":"5","author":"Mohanraj","year":"2007","journal-title":"Trop J Pharm Res"},{"key":"10.1016\/j.thromres.2014.05.009_bb0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0169-409X(00)00122-8","article-title":"Nanoparticulate systems for brain delivery of drugs","volume":"47","author":"Kreuter","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.thromres.2014.05.009_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.10.021","article-title":"Nanoparticles-a historical perspective","volume":"331","author":"Kreuter","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.thromres.2014.05.009_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems","volume":"75","author":"Kumari","year":"2010","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.thromres.2014.05.009_bb0060","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0168-3659(01)00342-X","article-title":"Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier","volume":"74","author":"Mitra","year":"2001","journal-title":"J Control Release"},{"key":"10.1016\/j.thromres.2014.05.009_bb0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-5173(02)00461-1","article-title":"Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A","volume":"249","author":"El-Shabouri","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.thromres.2014.05.009_bb0070","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1113\/jphysiol.1963.sp007185","article-title":"The aggregation of blood platelets","volume":"168","author":"Born","year":"1963","journal-title":"J Physiol"},{"key":"10.1016\/j.thromres.2014.05.009_bb0075","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/sj.bjp.0706786","article-title":"Counteracting effect of glycyrrhizin on the hemostatic abnormalities induced by Bothrops jararaca snake venom","volume":"148","author":"Assafim","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.thromres.2014.05.009_bb0080","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0968-0896(03)00055-5","article-title":"Antiplatelet properties of novel N-substituted-phenyl-1, 2, 3-triazole-4-acylhydrazone derivatives","volume":"11","author":"Cunha","year":"2003","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.thromres.2014.05.009_bb0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijbiomac.2004.12.002","article-title":"Anticoagulant and antithrombotic activities of a chemically sulfated galactoglucomannan obtained from the lichen Cladonia ibitipocae","volume":"35","author":"Martinichen-Herrero","year":"2005","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.thromres.2014.05.009_bb0090","series-title":"Qu\u00edmica medicinal: as bases moleculares da a\u00e7\u00e3o dos f\u00e1rmacos","author":"Barreiro","year":"2008"},{"key":"10.1016\/j.thromres.2014.05.009_bb0095","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-4274(85)90046-3","article-title":"Toxicity determined in vitro by morphological alterations and neutral red absorption","volume":"24","author":"Borenfreund","year":"1985","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.thromres.2014.05.009_bb0100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0009-3084(93)90070-J","article-title":"Toxicity screening of liposomes","volume":"64","author":"Parnham","year":"1993","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.thromres.2014.05.009_bb0105","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/mabi.201200017","article-title":"Poly(2-ethyl-2-oxazoline) as alternative for the stealth polymer poly(ethylene glycol): comparison of in vitro cytotoxicity and hemocompatibility","volume":"12","author":"Bauer","year":"2012","journal-title":"Macromol Biosci"},{"key":"10.1016\/j.thromres.2014.05.009_bb0110","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0142-9612(02)00445-3","article-title":"In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis","volume":"24","author":"Fischer","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.thromres.2014.05.009_bb0115","series-title":"Mutag\u00eanese, teratog\u00eanese e carcinog\u00eanese: M\u00e9todos e crit\u00e9rios de avalia\\cc\u00e3o","author":"Rabello-Gay","year":"1991"},{"key":"10.1016\/j.thromres.2014.05.009_bb0120","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1128\/AAC.06404-11","article-title":"Evaluation of arylimidamides DB1955 and DB1960 as candidates against visceral leishmaniasis and Chagas\u2019 disease: in vivo efficacy, acute toxicity, pharmacokinetics, and toxicology studies","volume":"56","author":"Zhu","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.thromres.2014.05.009_bb0125","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1007\/s11095-012-0690-z","article-title":"Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage","volume":"29","author":"Li","year":"2012","journal-title":"Pharm Res"},{"key":"10.1016\/j.thromres.2014.05.009_bb0130","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejmech.2007.03.032","article-title":"Synthesis and anti-platelet activity of novel arylsulfonate-acylhydrazone derivatives, designed as antithrombotic candidates","volume":"43","author":"Lima","year":"2008","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.thromres.2014.05.009_bb0135","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1081\/DDC-100102197","article-title":"Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method","volume":"25","author":"Barichello","year":"1999","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.thromres.2014.05.009_bb0140","first-page":"1066","article-title":"Farmacopeia Brasileira","volume":"2","author":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria","year":"2010","journal-title":"Farmacopeia Brasileira"},{"key":"10.1016\/j.thromres.2014.05.009_bb0145","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/jbm.a.32163","article-title":"Preparation, characterization, in-vitro drug release and cellular uptake of poly(caprolactone) grafted dextran copolymeric nanoparticles loaded with anticancer drug","volume":"90","author":"Prabu","year":"2009","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.thromres.2014.05.009_bb0150","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1172\/JCI575","article-title":"Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation","volume":"101","author":"Gresele","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.thromres.2014.05.009_bb0155","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000092416","article-title":"Bothrojaracin, a Bothrops jararaca snake venom-derived (pro)thrombin inhibitor, as an anti-thrombotic molecule","volume":"34","author":"Zingali","year":"2005","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.thromres.2014.05.009_bb0160","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1432-1033.1994.tb20069.x","article-title":"Reactions of prostaglandin H synthase with monosubstituted hydrazines and diazenes. Formation of iron(II)-diazene and iron(III)-sigma-alkyl or iron(III)-sigma-aryl complexes","volume":"226","author":"Mahy","year":"1994","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.thromres.2014.05.009_bb0165","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1016\/j.bmc.2004.04.009","article-title":"New class of potent antinociceptive and antiplatelet 10H-phenothiazine-1-acylhydrazone derivatives","volume":"12","author":"Silva","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.thromres.2014.05.009_bb0170","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2008.01.001","article-title":"Thromboxane A2: physiology\/pathophysiology, cellular signal transduction and pharmacology","volume":"118","author":"Nakahata","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.thromres.2014.05.009_bb0175","doi-asserted-by":"crossref","first-page":"730","DOI":"10.5551\/jat.3293","article-title":"Antiplatelet activity and structure-activity relationship study of Pyrazolopyridine Derivatives as potential series for treating thrombotic diseases","volume":"17","author":"Geraldo","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.thromres.2014.05.009_bb0180","first-page":"1","article-title":"Human thromboxane synthase: comparative modeling and docking evaluation with the competitive inhibitors Dazoxiben and Ozagrel","volume":"28","author":"Sathler","year":"2013","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.thromres.2014.05.009_bb0185","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1016\/j.bmcl.2012.03.059","article-title":"Synthesis and evaluation of anti-thrombotic activity of benzocoumarin amide derivatives","volume":"22","author":"Sashidhara","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.thromres.2014.05.009_bb0190","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.RES.78.4.643","article-title":"Inhibitory effects of TA-993, a new 1,5-benzothiazepine derivative, on platelet aggregation","volume":"78","author":"Odawara","year":"1996","journal-title":"Circ Res"},{"key":"10.1016\/j.thromres.2014.05.009_bb0195","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/000163599428544","article-title":"Cytotoxic effects of extracts of compomers","volume":"57","author":"Sletten","year":"1999","journal-title":"Acta Odontol Scand"},{"key":"10.1016\/j.thromres.2014.05.009_bb0200","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejmech.2012.02.005","article-title":"Synthesis and photodynamic properties of adamantylethoxy Zn(II) phthalocyanine derivatives in different media and in human red blood cells","volume":"50","author":"Ochoa","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.thromres.2014.05.009_bb0205","doi-asserted-by":"crossref","first-page":"15870","DOI":"10.1021\/ja045664d","article-title":"Tuning the Hemolytic and Antibacterial Activities of Amphiphilic Polynorbornene Derivatives","volume":"126","author":"Ilker","year":"2004","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.thromres.2014.05.009_bb0210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11010-012-1250-x","article-title":"Cyclophosphamide-induced nephrotoxicity, genotoxicity, and damage in kidney genomic DNA of Swiss albino mice: the protective effect of Ellagic acid","volume":"365","author":"Rehman","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.thromres.2014.05.009_bb0215","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0272-6386(96)90565-X","article-title":"Does aspirin cause acute or chronic renal failure in experimental animals and in humans?","volume":"28","author":"D'Agati","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.thromres.2014.05.009_bb0220","first-page":"310","article-title":"Multisystem toxicity of indomethacin: effects on kidney, liver and intestine in the rat","volume":"22","author":"Fracasso","year":"1987","journal-title":"Inflamm Res"},{"key":"10.1016\/j.thromres.2014.05.009_bb0225","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1001\/jama.1992.03490200097011","article-title":"Allergic reactions to drugs and biological agents","volume":"268","author":"Anderson","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2014.05.009_bb0230","first-page":"35","article-title":"Uso de antiinflamat\u00f3rios n\u00e3o-hormonais em crian\u00e7as com doen\u00e7as virais vs risco potencial para s\u00edndrome de Reye e doen\u00e7as invasivas graves por estreptococos do grupo A","volume":"22","author":"Bricks","year":"2000","journal-title":"Pediatria (S\u00e3o Paulo)"},{"key":"10.1016\/j.thromres.2014.05.009_bb0235","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ijpharm.2012.07.052","article-title":"PLA nanoparticles coated with a \u03b2-cyclodextrin polymer shell: preparation, characterization and release kinetics of a hydrophobic compound","volume":"436","author":"El Fagui","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.thromres.2014.05.009_bb0240","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.indcrop.2013.08.015","article-title":"Optimization of \u03b1-tocopherol loaded nanocapsules by the nanoprecipitation method","volume":"50","author":"Noronha","year":"2013","journal-title":"Ind Crop Prod"},{"key":"10.1016\/j.thromres.2014.05.009_bb0245","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejpb.2010.07.007","article-title":"Rivastigmine-loaded PLGA and PBCA nanoparticles: Preparation, optimization, characterization,<i> in vitro <\/i> and pharmacodynamic studies","volume":"76","author":"Joshi","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.thromres.2014.05.009_bb0250","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1359-0286(02)00117-1","article-title":"Biodegradable nanoparticles for drug delivery and targeting","volume":"6","author":"Hans","year":"2002","journal-title":"Curr Opinion Solid State Mater Sci"},{"key":"10.1016\/j.thromres.2014.05.009_bb0255","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissue","volume":"55","author":"Panyam","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.thromres.2014.05.009_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2007.08.001","article-title":"Nanoparticles for drug delivery: the need for precision in reporting particle size parameters","volume":"69","author":"Gaumet","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.thromres.2014.05.009_bb0265","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jconrel.2009.08.011","article-title":"Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel","volume":"140","author":"Danhier","year":"2009","journal-title":"J Control Release"},{"key":"10.1016\/j.thromres.2014.05.009_bb0270","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijpharm.2008.09.061","article-title":"Optimized stability retention of a monoclonal antibody in the PLGA nanoparticles","volume":"368","author":"Son","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.thromres.2014.05.009_bb0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.supflu.2013.01.009","article-title":"Monodisperse biopolymer nanoparticles by Continuous Supercritical Emulsion Extraction","volume":"76","author":"Della Porta","year":"2013","journal-title":"J Supercrit Fluids"},{"key":"10.1016\/j.thromres.2014.05.009_bb0280","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0006-3495(84)84252-6","article-title":"Cell adhesion. Competition between nonspecific repulsion and specific bonding","volume":"45","author":"Bell","year":"1984","journal-title":"Biophys J"},{"key":"10.1016\/j.thromres.2014.05.009_bb0285","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.biomaterials.2007.09.025","article-title":"Design maps for nanoparticles targeting the diseased microvasculature","volume":"29","author":"Decuzzi","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.thromres.2014.05.009_bb0290","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1590\/S0100-40422003000500017","article-title":"Caracteriza\u00e7\u00e3o e estabilidade f\u00edsico-qu\u00edmica de sistemas polim\u00e9ricos nanoparticulados para administra\u00e7\u00e3o de f\u00e1rmacos","volume":"26","author":"Schaffazick","year":"2003","journal-title":"Qu\u00edmica Nova"},{"key":"10.1016\/j.thromres.2014.05.009_bb0295","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.2147\/IJN.S32630","article-title":"Effects of polymer molecular weight on relative oral bioavailability of curcumin","volume":"7","author":"Tsai","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.thromres.2014.05.009_bb0300","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1021\/jf202135j","article-title":"PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms","volume":"59","author":"Xie","year":"2011","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.thromres.2014.05.009_bb0305","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijpharm.2006.10.025","article-title":"Improved bioavailability of orally administered mifepristone from PLGA nanoparticles","volume":"334","author":"He","year":"2007","journal-title":"Int J Pharm"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814002746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814002746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T01:27:58Z","timestamp":1538616478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384814002746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0049384814002746"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2014.05.009","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo analysis of the antithrombotic and toxicological profile of new antiplatelets N-acylhydrazone derivatives and development of nanosystems","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2014.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}